Business Context and Reporting Period
Company: RXi Pharmaceuticals Corporation (Note: Metadata lists "Phio Pharmaceuticals Corp.", but the filing text identifies the registrant as RXi Pharmaceuticals Corporation).
Filing Type: Form 8-K (Current Report)
Date of Report: May 7, 2015
Event: Notice of potential delisting due to failure to meet Nasdaq minimum bid price requirements.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
The filing text does not provide a clear value for financial metrics.
Material Changes
- Listing Status: The Company received a Notification Letter from the Nasdaq Stock Market stating it is not in compliance with Nasdaq Listing Rule 5550(a)(2).
- Compliance Deficiency: The Company's common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days prior to May 7, 2015.
- Current Impact: The notification does not immediately impact the Company's listing on The Nasdaq Capital Market.
Guidance, Outlook, and Risks
- Compliance Deadline: The Company has 180 calendar days (until November 3, 2015) to regain compliance.
- Path to Compliance: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days prior to the November 3, 2015 deadline.
- Contingency: If the Company fails to regain compliance by the deadline, it may be eligible for additional time to reach compliance.
- Risk: Failure to meet the bid price requirement could result in delisting from The Nasdaq Capital Market.
Investor Verification Checklist
- Verify the current trading price of RXi Pharmaceuticals Corporation common stock to assess proximity to the $1.00 threshold.
- Monitor the Company's stock price performance over the next 10 consecutive business days to determine if compliance is achieved.
- Review future filings for updates on the Company's status regarding the November 3, 2015 deadline.
- Confirm the Company's name and ticker symbol, as the metadata provided ("Phio Pharmaceuticals Corp.") differs from the registrant name in the text ("RXi Pharmaceuticals Corporation").